Amphastar Pharmaceuticals (AMPH) Profit After Tax Growth (5y) (2018 - 2026)
Amphastar Pharmaceuticals (AMPH) Profit After Tax Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Amphastar Pharmaceuticals | 938.35 Mn | 648.22 Mn | 93.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.33% |
| Mar 31, 2026 | 4.96% |
| Dec 31, 2025 | 44.12% |
| Sep 30, 2025 | 34.66% |
| Jun 30, 2025 | 154.96% |
| Mar 31, 2025 | 44.97% |
| Dec 31, 2024 | 107.47% |
| Sep 30, 2024 | 98.56% |
| Jun 30, 2024 | -4.51% |
| Mar 31, 2024 | 118.45% |
| Dec 31, 2023 | 82.84% |
| Sep 30, 2023 | 83.43% |
| Jun 30, 2023 | 62.00% |
| Mar 31, 2023 | 41.36% |
| Dec 31, 2022 | 113.72% |
| Sep 30, 2022 | 176.06% |
| Jun 30, 2022 | 55.63% |
| Mar 31, 2022 | 94.96% |
| Dec 31, 2021 | 55.89% |
| Sep 30, 2021 | 51.42% |